Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Synergism between Prior Anisakis simplex Infections and Intake of NSAIDs, on the Risk of Upper Digestive Bleeding: A Case-Control Study. PMID: 21738810 Journal: PLoS Neglected Tropical Diseases Year: 2011 Reference: PLoS Negl Trop Dis. 2011 Jun;5(6):e1214. Epub 2011 Jun 28. Impact factor: 4.752 Publication type: Paper in international publication Authors: Lopez-Goikoetxea, Maria Jose, Ibanez, Luisa, Figueiras, Adolfo, Aguirre, Carmelo, Ortega, Sara, Salgado, Angel, Ubeira, Florencio M, Anadon, Ana M, Carvajal, Alfonso et al. DOI: 10.1371/journal.pntd.0001214 Synergism between Prior Anisakis simplex Infections and Intake of NSAIDs, on the Risk of Upper Digestive Bleeding: A Case-Control Study. PMID: 21738810 Journal: PLoS Neglected Tropical Diseases Year: 2011 Reference: PLoS Negl Trop Dis. 2011 Jun;5(6):e1214. Epub 2011 Jun 28. Impact factor: Publication type: Paper in international publication Authors: Aguirre, Carmelo; Anadon, Ana M; Carvajal, Alfonso; Figueiras, Adolfo; Ibanez, Luisa; Lopez-Goikoetxea, Maria Jose; Ortega, Sara; Salgado, Angel; Ubeira, Florencio M et al. DOI: 10.1371/journal.pntd.0001214 Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism. PMID: 21600050 Journal: BREAST CANCER RESEARCH Year: 2011 Reference: Breast Cancer Res. 2011 May 22;13(3):R54. Impact factor: 5.785 Publication type: Paper in international publication Authors: , , , et al. DOI: 10.1186/bcr2888 Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism. PMID: 21600050 Journal: BREAST CANCER RESEARCH Year: 2011 Reference: Breast Cancer Res. 2011 May 22;13(3):R54. Impact factor: Publication type: Paper in international publication Authors: ; ; ; et al. DOI: 10.1186/bcr2888 Synovial fibroblast hyperplasia in rheumatoid arthritis: Clinicopathological correlations and partial reversal by anti-tumor necrosis factor therapy. PMID: 21547893 Journal: ARTHRITIS AND RHEUMATISM Year: 2011 Reference: Arthritis Rheum. 2011 Sep;63(9):2575-83. doi: 10.1002/art.30433. Impact factor: 8.435 Publication type: Paper in international publication Authors: , , , , , , , , et al. DOI: 10.1002/art.30433 Synovial fibroblast hyperplasia in rheumatoid arthritis: Clinicopathological correlations and partial reversal by anti-tumor necrosis factor therapy. PMID: 21547893 Journal: ARTHRITIS AND RHEUMATISM Year: 2011 Reference: Arthritis Rheum. 2011 Sep;63(9):2575-83. doi: 10.1002/art.30433. Impact factor: Publication type: Paper in international publication Authors: ; ; ; ; ; ; ; ; et al. DOI: 10.1002/art.30433 Systematic reviews and meta-analysis: scientific rationale and interpretation. PMID: 21719182 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2011 Reference: Rev Esp Cardiol. 2011 Aug;64(8):688-96. Epub 2011 Jun 30. Impact factor: 2.157 Publication type: Review in national publication Authors: Ferreira Gonzalez, Ignacio, Urrutia, Gerard, Alonso-Coello, Pablo et al. DOI: 10.1016/j.recesp.2011.03.029 Systematic reviews and meta-analysis: scientific rationale and interpretation. PMID: 21719182 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2011 Reference: Rev Esp Cardiol. 2011 Aug;64(8):688-96. Epub 2011 Jun 30. Impact factor: Publication type: Review in national publication Authors: Alonso-Coello, Pablo; Ferreira Gonzalez, Ignacio; Urrutia, Gerard et al. DOI: 10.1016/j.recesp.2011.03.029 Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms. PMID: 19851769 Journal: RHEUMATOLOGY INTERNATIONAL Year: 2011 Reference: Rheumatol Int. 2011 Apr;31(4):537-41. Epub 2009 Oct 23. Impact factor: 1.431 Publication type: Paper in international publication Authors: , , , , et al. DOI: 10.1007/s00296-009-1209-8 Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms. PMID: 19851769 Journal: RHEUMATOLOGY INTERNATIONAL Year: 2011 Reference: Rheumatol Int. 2011 Apr;31(4):537-41. Epub 2009 Oct 23. Impact factor: Publication type: Paper in international publication Authors: ; ; ; ; et al. DOI: 10.1007/s00296-009-1209-8 T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. PMID: 20627965 Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Year: 2011 Reference: J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. Epub 2010 Jul 13. Impact factor: 4.791 Publication type: Paper in international publication Authors: , , , , , , , , , et al. DOI: 10.1136/jnnp.2009.201574 T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. PMID: 20627965 Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Year: 2011 Reference: J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. Epub 2010 Jul 13. Impact factor: Publication type: Paper in international publication Authors: ; ; ; ; ; ; ; ; ; et al. DOI: 10.1136/jnnp.2009.201574 Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity. PMID: 21382338 Journal: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Year: 2011 Reference: Biochem Biophys Res Commun. 2011 Apr 8;407(2):333-8. Epub 2011 Mar 5. Impact factor: 2.595 Publication type: Paper in international publication Authors: , , , , , , , et al. DOI: 10.1016/j.bbrc.2011.03.018 Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity. PMID: 21382338 Journal: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Year: 2011 Reference: Biochem Biophys Res Commun. 2011 Apr 8;407(2):333-8. Epub 2011 Mar 5. Impact factor: Publication type: Paper in international publication Authors: ; ; ; ; ; ; ; et al. DOI: 10.1016/j.bbrc.2011.03.018 Targeted therapies development in the treatment of advanced nonsmall cell lung cancer. PMID: 22219656 Journal: JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY Year: 2011 Reference: J Biomed Biotechnol. 2011;2011:415641. Epub 2011 Dec 18. Impact factor: 1.225 Publication type: Editorail in international publication Authors: Gridelli, Cesare, Felip, Enriqueta et al. DOI: 10.1155/2011/415641 Targeted therapies development in the treatment of advanced nonsmall cell lung cancer. PMID: 22219656 Journal: JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY Year: 2011 Reference: J Biomed Biotechnol. 2011;2011:415641. Epub 2011 Dec 18. Impact factor: Publication type: Editorail in international publication Authors: Felip, Enriqueta; Gridelli, Cesare et al. DOI: 10.1155/2011/415641 Telaprevir for retreatment of HCV infection. PMID: 21696308 Journal: NEW ENGLAND JOURNAL OF MEDICINE Year: 2011 Reference: N Engl J Med. 2011 Jun 23;364(25):2417-28. Impact factor: 53.484 Publication type: Paper in international publication Authors: Picchio, Gaston, Pol, Stanislas, Lawitz, Eric, Diago, Moises, Roberts, Stuart, Focaccia, Roberto, Younossi, Zobair, Foster, Graham R, Horban, Andrzej, Ferenci, Peter et al. DOI: 10.1056/NEJMoa1013086 Telaprevir for retreatment of HCV infection. PMID: 21696308 Journal: NEW ENGLAND JOURNAL OF MEDICINE Year: 2011 Reference: N Engl J Med. 2011 Jun 23;364(25):2417-28. Impact factor: Publication type: Paper in international publication Authors: Afdhal, Nezam; Agarwal, Kaushik; Andreone, Pietro; Andreone, Pietro; Arora, Sanjeev; Ascione, Antonio; Baruch, Yaacov; Benari, Ziv; Benhamou, Yves; Berg, Thomas et al. DOI: 10.1056/NEJMoa1013086 Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease. PMID: 21254162 Journal: HEPATOLOGY Year: 2011 Reference: Hepatology. 2011 Jan;53(1):62-72. doi: 10.1002/hep.23952. Epub 2010 Oct 27. Impact factor: 10.885 Publication type: Paper in international publication Authors: Liaw, Yun-Fan, Sheen, I-Shyan, Lee, Chuan-Mo, Akarca, Ulus Salih, Papatheodoridis, George V, Suet-Hing Wong, Florence, Chang, Ting-Tsung, Horban, Andrzej, Wang, Chia, Kwan, Peter et al. DOI: 10.1002/hep.23952 Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease. PMID: 21254162 Journal: HEPATOLOGY Year: 2011 Reference: Hepatology. 2011 Jan;53(1):62-72. doi: 10.1002/hep.23952. Epub 2010 Oct 27. Impact factor: Publication type: Paper in international publication Authors: Akarca, Ulus Salih; Berg, Thomas; Buti, Maria; Chang, Ting-Tsung; Frederick, David; Horban, Andrzej; Kitrinos, Kathryn; Kwan, Peter; Lee, Chuan-Mo; Liaw, Yun-Fan et al. DOI: 10.1002/hep.23952 THC and CBD oromucosal spray (Sativex((R))) in the management of spasticity associated with multiple sclerosis. PMID: 21456949 Journal: Expert review of neurotherapeutics Year: 2011 Reference: Expert Rev Neurother. 2011 May;11(5):627-37. Epub 2011 Apr 1. Impact factor: Publication type: Letter or abstract Authors: , , , et al. DOI: 10.1586/ern.11.47 THC and CBD oromucosal spray (Sativex((R))) in the management of spasticity associated with multiple sclerosis. PMID: 21456949 Journal: Expert review of neurotherapeutics Year: 2011 Reference: Expert Rev Neurother. 2011 May;11(5):627-37. Epub 2011 Apr 1. Impact factor: Publication type: Letter or abstract Authors: ; ; ; et al. DOI: 10.1586/ern.11.47 The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy. PMID: 21811581 Journal: PLoS One Year: 2011 Reference: PLoS One. 2011;6(7):e22284. Epub 2011 Jul 21. Impact factor: 4.411 Publication type: Paper in international publication Authors: Annibali, Daniela, Carucci, Nicoletta, Favuzzi, Emilia, Cole, Michael D, Evan, Gerard I, Soucek, Laura, Nasi, Sergio, Savino, Mauro et al. DOI: 10.1371/journal.pone.0022284 The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy. PMID: 21811581 Journal: PLoS One Year: 2011 Reference: PLoS One. 2011;6(7):e22284. Epub 2011 Jul 21. Impact factor: Publication type: Paper in international publication Authors: Annibali, Daniela; Carucci, Nicoletta; Cole, Michael D; Evan, Gerard I; Favuzzi, Emilia; Nasi, Sergio; Savino, Mauro; Soucek, Laura et al. DOI: 10.1371/journal.pone.0022284 Pagination First page « First Previous page ‹ Previous … Page 1600 Page 1601 Page 1602 Page 1603 Current page 1604 Page 1605 Page 1606 Page 1607 Page 1608 … Next page Next › Last page Last »